We use analytics and advertising cookies, which you can accept or reject; see our privacy policy.

Current choice:

S1P Receptor

Sphingosine-1-phosphate (S1P) receptor modulators act on S1PR1 to S1PR5, five G protein-coupled lipid receptors. In 1998 S1P was identified as a ligand of the orphan receptor endothelial differentiation gene 1 (EDG-1), now called S1PR1. FTY720 (fingolimod) was shown in 2002 to be phosphorylated in vivo and to act on four of the five S1P receptors. Two years later, lymphocyte egress from thymus and lymph nodes was found to depend on S1PR1. Ozanimod, BAF312 and ponesimod are further S1PR1-directed modulators, CYM 5442 HCl is a selective S1PR1 agonist and TY-52156 blocks S1PR3. Opaganib inhibits sphingosine kinase 2 (SphK2) and so limits S1P synthesis upstream of the receptors.

1 Item

  • C16-Sphingosine-1-phosphate
    Cat. No.
    A61210
    CAS No.
    709026-60-8

    C16-Sphingosine-1-phosphate

    C16-Sphingosine-1-phosphate is a derivative of Sphingosine-1-phosphate, functioning as an endogenous ligand for the EDG/S1P receptor. This compound exhibits key biological activity in modulating signaling pathways related to angiogenesis and inflammation. It is a valuable reagent for research applications focused on cardiovascular diseases and related physiological processes.

    In stock View Details
    0.5 mg
    $570.00
    1 mg
    $685.00
    All 3 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...